Drospirenone is a medication marketed by numerous companies including Exeltis USA and Mylan Labs. The drug is protected by thirteen patents and has fifty-five patent family members in twenty-nine countries. The generic ingredient in Drospirenone is drospirenone; ethinyl estradiol; levomefolate calcium. Additional information can be found on the DrugPatentWatch website.
Q&A: Nurses Are Key Stakeholders in Healthcare’s AI Journey
Nurses’ contribution is key to AI success within healthcare, through both their support and skepticism of AI tools, according to Ryan from HealthTech. Ryan highlighted
